CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

AMGN's EPS from Cont. Operations Growth by Quarter and Year

Amgen Inc 's EPS from Cont. Operations results by quarter and year




AMGN EPS from Cont. Operations (in $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 2.78 2.88 3.05
III Quarter September - 3.45 3.29 2.88
II Quarter June - 3.07 3.59 3.50
I Quarter March 2.85 3.09 3.20 3.27
FY   2.85 12.39 12.96 12.70



AMGN EPS from Cont. Operations first quarter 2021 Y/Y Growth Comment
Amgen Inc reported decrease in EPS from Cont. Operations in the first quarter by -7.77% to $ 2.85 , from the same quarter in 2020.
The decrease in the first quarter Amgen Inc 's EPS from Cont. Operations compares unfavorably to the Company's average EPS from Cont. Operations growth of 5.62%.

Looking into first quarter results within Biotechnology & Drugs industry 2 other companies have achieved higher EPS from Cont. Operations growth. While Amgen Inc ' s EPS from Cont. Operations decline of -7.77% ranks overall at the positon no. 210 in the first quarter.




AMGN EPS from Cont. Operations ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - -3.47 % -5.57 % -
III Quarter September - 4.86 % 14.24 % 3.6 %
II Quarter June - -14.48 % 2.57 % 19.45 %
I Quarter March -7.77 % -3.44 % -2.14 % 16.37 %
FY   - -4.4 % 2.05 % 381.06 %

Financial Statements
Amgen Inc 's first quarter 2021 EPS from Cont. Operations $ 2.85 AMGN's Income Statement
Amgen Inc 's first quarter 2020 EPS from Cont. Operations $ 3.09 Quarterly AMGN's Income Statement
New: More AMGN's historic EPS from Cont. Operations Growth >>


AMGN EPS from Cont. Operations (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - -19.42 % -12.46 % 5.9 %
III Quarter September - 12.38 % -8.36 % -17.71 %
II Quarter June - -0.65 % 12.19 % 7.03 %
I Quarter March 2.52 % 7.29 % 4.92 % -
FY (Year on Year)   - -4.4 % 2.05 % 381.06 %




EPS from Cont. Operations first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #3
Healthcare Sector #12
Overall #210

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
236.99 % 5.62 % -76.3 %
(Dec 31 2018)   (Dec 31 2017)
EPS from Cont. Operations first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #3
Healthcare Sector #12
Overall #210
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
236.99 % 5.62 % -76.3 %
(Dec 31 2018)   (Dec 31 2017)

EPS from Cont. Operations by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Amgen Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
9300 % 147.95 % -98.8 %
(Sep. 30, 2006)  


AMGN's I. Quarter Q/Q EPS from Cont. Operations Comment
Amgen Inc achieved in the I. Quarter 2021 below company average EPS from Cont. Operations growth of 2.52% quarter on quarter, to $ 2.85 .

Within Biotechnology & Drugs industry 2 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Amgen Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is 122.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #3
Healthcare Sector #7
Overall #122
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #3
Healthcare Sector #7
Overall #122
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
9300 % 147.95 % -98.8 %
(Sep. 30, 2006)  


AMGN's I. Quarter Q/Q EPS from Cont. Operations Comment
Amgen Inc achieved in the I. Quarter 2021 below company average EPS from Cont. Operations growth of 2.52% quarter on quarter, to $ 2.85 .

Within Biotechnology & Drugs industry 2 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Amgen Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is 122.


Amgen Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative EPS from Cont. Operations 12 Months Ending $ 12.15 $ 12.39 $ 12.49 $ 12.33 $ 12.85
Y / Y EPS from Cont. Operations Growth (TTM) -5.43 % -4.38 % -4.9 % -3.09 % 1.72 %
Year on Year EPS from Cont. Operations Growth Overall Ranking # 985 # 231 # 871 # 815 # 699
Seqeuential EPS from Cont. Operations Change (TTM) -1.94 % -0.78 % 1.3 % -4.05 % -0.85 %
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # 1491 # 856 # 336 # 1007 # 779




Cumulative EPS from Cont. Operations growth Comment
Amgen Inc 's cumulative 12 months EPS from Cont. Operations continue to decrease, but on the faster rate at -5.43% year on year, at Mar 31 2021 compare to the -4.38% decrease at Dec 31 2020. If the Amgen Inc 's fiscal year would end at Mar 31 2021, annual EPS from Cont. Operations would be $12 .

In the Healthcare sector 61 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While EPS from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 231 to 985.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
236.99 %
5.62 %
-76.3 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 20
Healthcare Sector # 62
Overall # 985

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
381.31 %
26.99 %
-74.44 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 20
Sector # 103
S&P 500 # 1491
Cumulative EPS from Cont. Operations growth Comment
Amgen Inc 's cumulative 12 months EPS from Cont. Operations continue to decrease, but on the faster rate at -5.43% year on year, at Mar 31 2021 compare to the -4.38% decrease at Dec 31 2020. If the Amgen Inc 's fiscal year would end at Mar 31 2021, annual EPS from Cont. Operations would be $12 .

In the Healthcare sector 61 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While EPS from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 231 to 985.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
236.99 %
5.62 %
-76.3 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 20
Healthcare Sector # 62
Overall # 985

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
381.31 %
26.99 %
-74.44 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 20
Sector # 103
S&P 500 # 1491




Other EPS from Cont. Operations Growth
Biotechnology & Drugs Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
AMGN's EPS from Cont. Operations Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for AMGN's Competitors
EPS from Cont. Operations Growth for Amgen Inc 's Suppliers
EPS from Cont. Operations Growth for AMGN's Customers

You may also want to know
AMGN's Annual Growth Rates AMGN's Profitability Ratios AMGN's Asset Turnover Ratio AMGN's Dividend Growth
AMGN's Roe AMGN's Valuation Ratios AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio
AMGN's Roa AMGN's Inventory Turnover Ratio AMGN's Growth Rates AMGN's Dividend Comparisons



Companies with similar EPS from Cont. Operations decrease for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Mar 31 2021
Merck and Co Inc -0.79%$ -0.787 
Abbvie Inc -0.99%$ -0.990 
Utah Medical Products Inc-2.35%$ -2.353 
89bio Inc -2.63%$ -2.632 
Petmed Express Inc-3.29%$ -3.294 
Prestige Consumer Healthcare Inc -3.51%$ -3.507 
Eli Lilly And Company-6.88%$ -6.875 
Amgen Inc -7.77%$ -7.767 
Phibro Animal Health Corp-9.09%$ -9.091 
Baxter International Inc -9.23%$ -9.231 
Atrion Corporation-11.88%$ -11.875 
Neurocrine Biosciences Inc -15.00%$ -15.000 
Msa Safety Inc-16.96%$ -16.964 
Corcept Therapeutics Inc-23.08%$ -23.077 
National Research Corporation-23.40%$ -23.404 
Iradimed Corp-26.67%$ -26.667 
Steris Plc-28.25%$ -28.253 
Catalyst Pharmaceuticals Inc -30.00%$ -30.000 
Alpha Pro Tech Ltd-31.71%$ -31.707 
Acadia Healthcare Company Inc -34.21%$ -34.211 
Stryker Corp-39.39%$ -39.394 
Teleflex Incorporated-43.46%$ -43.463 
Fonar Corp-45.00%$ -45.000 
Anika Therapeutics Inc -51.22%$ -51.220 
Vyne Therapeutics Inc -55.79%$ -55.789 
Electromed Inc -62.50%$ -62.500 
Viemed Healthcare Inc -63.64%$ -63.636 
Edwards Lifesciences Corporation-63.76%$ -63.758 
Biogen Inc -66.67%$ -66.667 
Endo International Plc-71.01%$ -71.014 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ONEM's Profile

Stock Price

ONEM's Financials

Business Description

Fundamentals

Charts & Quotes

ONEM's News

Suppliers

ONEM's Competitors

Customers & Markets

Economic Indicators

ONEM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071